These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15912449)

  • 1. Glyco-engineering of moss lacking plant-specific sugar residues.
    Huether CM; Lienhart O; Baur A; Stemmer C; Gorr G; Reski R; Decker EL
    Plant Biol (Stuttg); 2005 May; 7(3):292-9. PubMed ID: 15912449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans.
    Koprivova A; Stemmer C; Altmann F; Hoffmann A; Kopriva S; Gorr G; Reski R; Decker EL
    Plant Biotechnol J; 2004 Nov; 2(6):517-23. PubMed ID: 17147624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moss-based production of asialo-erythropoietin devoid of Lewis A and other plant-typical carbohydrate determinants.
    Parsons J; Altmann F; Arrenberg CK; Koprivova A; Beike AK; Stemmer C; Gorr G; Reski R; Decker EL
    Plant Biotechnol J; 2012 Sep; 10(7):851-61. PubMed ID: 22621344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of fucose residues in plant N-glycans by repression of the GDP-mannose 4,6-dehydratase gene using virus-induced gene silencing and RNA interference.
    Matsuo K; Matsumura T
    Plant Biotechnol J; 2011 Feb; 9(2):264-81. PubMed ID: 20731789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-level expression of secreted complex glycosylated recombinant human erythropoietin in the Physcomitrella Delta-fuc-t Delta-xyl-t mutant.
    Weise A; Altmann F; Rodriguez-Franco M; Sjoberg ER; Bäumer W; Launhardt H; Kietzmann M; Gorr G
    Plant Biotechnol J; 2007 May; 5(3):389-401. PubMed ID: 17359496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of rat beta(1,4)-N-acetylglucosaminyltransferase III in Nicotiana tabacum remodels the plant-specific N-glycosylation.
    Frey AD; Karg SR; Kallio PT
    Plant Biotechnol J; 2009 Jan; 7(1):33-48. PubMed ID: 18778316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure.
    Strasser R; Stadlmann J; Schähs M; Stiegler G; Quendler H; Mach L; Glössl J; Weterings K; Pabst M; Steinkellner H
    Plant Biotechnol J; 2008 May; 6(4):392-402. PubMed ID: 18346095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo glyco-engineered antibody with improved lytic potential produced by an innovative non-mammalian expression system.
    Schuster M; Jost W; Mudde GC; Wiederkum S; Schwager C; Janzek E; Altmann F; Stadlmann J; Stemmer C; Gorr G
    Biotechnol J; 2007 Jun; 2(6):700-8. PubMed ID: 17427997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of recombinant human granulocyte macrophage-colony stimulating factor in rice cell suspension culture with a human-like N-glycan structure.
    Shin YJ; Chong YJ; Yang MS; Kwon TH
    Plant Biotechnol J; 2011 Dec; 9(9):1109-19. PubMed ID: 21801300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of Arabidopsis thaliana plants with complex N-glycans lacking beta1,2-linked xylose and core alpha1,3-linked fucose.
    Strasser R; Altmann F; Mach L; Glössl J; Steinkellner H
    FEBS Lett; 2004 Mar; 561(1-3):132-6. PubMed ID: 15013764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern.
    Schähs M; Strasser R; Stadlmann J; Kunert R; Rademacher T; Steinkellner H
    Plant Biotechnol J; 2007 Sep; 5(5):657-63. PubMed ID: 17678502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of plant-specific sugar residues in plant N-glycans by repression of GDP-D-mannose 4,6-dehydratase and β-1,2-xylosyltransferase genes.
    Matsuo K; Kagaya U; Itchoda N; Tabayashi N; Matsumura T
    J Biosci Bioeng; 2014 Oct; 118(4):448-54. PubMed ID: 24794851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein N-glycosylation is similar in the moss Physcomitrella patens and in higher plants.
    Viëtor R; Loutelier-Bourhis C; Fitchette AC; Margerie P; Gonneau M; Faye L; Lerouge P
    Planta; 2003 Dec; 218(2):269-75. PubMed ID: 14566560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fast and flexible PEG-mediated transient expression system in plants for high level expression of secreted recombinant proteins.
    Baur A; Kaufmann F; Rolli H; Weise A; Luethje R; Berg B; Braun M; Baeumer W; Kietzmann M; Reski R; Gorr G
    J Biotechnol; 2005 Oct; 119(4):332-42. PubMed ID: 15993971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplexed, targeted gene editing in Nicotiana benthamiana for glyco-engineering and monoclonal antibody production.
    Li J; Stoddard TJ; Demorest ZL; Lavoie PO; Luo S; Clasen BM; Cedrone F; Ray EE; Coffman AP; Daulhac A; Yabandith A; Retterath AJ; Mathis L; Voytas DF; D'Aoust MA; Zhang F
    Plant Biotechnol J; 2016 Feb; 14(2):533-42. PubMed ID: 26011187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A plant-derived human monoclonal antibody induces an anti-carbohydrate immune response in rabbits.
    Jin C; Altmann F; Strasser R; Mach L; Schähs M; Kunert R; Rademacher T; Glössl J; Steinkellner H
    Glycobiology; 2008 Mar; 18(3):235-41. PubMed ID: 18203810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled glycosylation of therapeutic antibodies in plants.
    Tekoah Y; Ko K; Koprowski H; Harvey DJ; Wormald MR; Dwek RA; Rudd PM
    Arch Biochem Biophys; 2004 Jun; 426(2):266-78. PubMed ID: 15158677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current achievements in the production of complex biopharmaceuticals with moss bioreactors.
    Decker EL; Reski R
    Bioprocess Biosyst Eng; 2008 Jan; 31(1):3-9. PubMed ID: 17701058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal C5-1 antibody produced in transgenic alfalfa plants exhibits a N-glycosylation that is homogenous and suitable for glyco-engineering into human-compatible structures.
    Bardor M; Loutelier-Bourhis C; Paccalet T; Cosette P; Fitchette AC; Vézina LP; Trépanier S; Dargis M; Lemieux R; Lange C; Faye L; Lerouge P
    Plant Biotechnol J; 2003 Nov; 1(6):451-62. PubMed ID: 17134403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of mouse monoclonal antibody with galactose-extended sugar chain by suspension cultured tobacco BY2 cells expressing human beta(1,4)-galactosyltransferase.
    Fujiyama K; Furukawa A; Katsura A; Misaki R; Omasa T; Seki T
    Biochem Biophys Res Commun; 2007 Jun; 358(1):85-91. PubMed ID: 17481579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.